Clinical Practice Study
Copyright ©The Author(s) 2018.
World J Transplant. Feb 24, 2018; 8(1): 23-37
Published online Feb 24, 2018. doi: 10.5500/wjt.v8.i1.23
Figure 2
Figure 2 Quantitative analysis of cultured CD4 + and CD8 + T lymphocytes from individual end-stage liver failure, end-stage renal failure and healthy control subjects. A: % CD4+CD69+INFγ+; B: CD4+CD69+IL-17+; C: CD4+CD69+IL-10+ cells in ESLF patients and HC individuals; D: % CD4+CD69+INF-γ+; E: CD8+CD69+IL-10+; F: CD4+CD69+IL-10+ cells in ESRF patients and HC individuals. The horizontal lines reflect median values for each group and vertical lines reflect interquartile range. ESLF: End-stage liver failure; ESRF: End-stage renal failure; HC: Healthy control.

  • Citation: Boix F, Llorente S, Eguía J, Gonzalez-Martinez G, Alfaro R, Galián JA, Campillo JA, Moya-Quiles MR, Minguela A, Pons JA, Muro M. In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients. World J Transplant 2018; 8(1): 23-37
  • URL: https://www.wjgnet.com/2220-3230/full/v8/i1/23.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v8.i1.23